{"id":25388,"date":"2024-06-07T13:11:40","date_gmt":"2024-06-07T11:11:40","guid":{"rendered":"https:\/\/cst.cat\/grup-recerca\/oncologia\/"},"modified":"2024-06-17T09:11:18","modified_gmt":"2024-06-17T07:11:18","slug":"oncologia","status":"publish","type":"grup_recerca","link":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/","title":{"rendered":"Oncolog\u00eda"},"content":{"rendered":"\n<p class=\"has-cyan-bluish-gray-color has-text-color\" style=\"font-size:12px\">GRUPOS DE INVESTIGACI\u00d3N<\/p>\n\n\n\n<h1 class=\"wp-block-heading\" id=\"oncologia\">Oncolog\u00eda<\/h1>\n\n\n\n<div style=\"height:39px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"membres\">Miembros<\/h2>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Remei Blanco Guerrero (PhD, MD)<br>Jordi Alfaro Gamero (MD)<br>Emma Dotor Navarro (MD)<br>Aleydis Pisa Gatell (MD)<br>Ana Raquel Jim\u00e9nez Macedo (MD)<br>Gemma Llort Pursals (MD)<br>Marta Andr\u00e9s Grany\u00f3 (MD)<br>Maria Mar\u00edn Alcal\u00e1 (MD)<br>Rosa Maria P\u00e9rez Ramos (MD)<br>M\u00f3nica Juncosa Domingo (MD)<br>Marc Campayo Guillaumes (PhD, MD)<br>Carme Aracil Noelle (PhD)<br>Lester Martinez Navarro  <br>Tania Estap\u00e9 Madinabeitia PhD (PC, NPS)<br>Gloria Arenas Mu\u00f1oz <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"linies-de-recerca\">L\u00edneas de investigaci\u00f3n<\/h2>\n\n\n\n<figure class=\"wp-block-table grups-recerca\"><table><tbody><tr><td><strong>Oncogeriatr\u00eda<\/strong><\/td><td>Identificaci\u00f3n de los problemas f\u00edsicos, funcionales, cognitivos y sociales con los que se enfrentan las personas mayores con c\u00e1ncer, a fin de adaptar el tratamiento en cada caso y planificar su seguimiento.<\/td><\/tr><tr><td><strong>Deporte, nutrici\u00f3n y estilos de vida<\/strong><\/td><td>Estudio de la relaci\u00f3n entre la actividad f\u00edsica, los h\u00e1bitos alimenticios y el estilo de vida con el c\u00e1ncer, tanto en su prevenci\u00f3n como en su impacto en resultados de salud.<\/td><\/tr><tr><td><strong>Biomarcadores en c\u00e1ncer<\/strong><\/td><td>Estudio de perfiles moleculares de los distintos tumores para la selecci\u00f3n y monitorizaci\u00f3n de tratamientos.<\/td><\/tr><tr><td><strong>Consejo gen\u00e9tico<\/strong><\/td><td>Estudio y caracterizaci\u00f3n del c\u00e1ncer hereditario, sus variantes gen\u00e9ticas y sus repercusiones cl\u00ednicas.<\/td><\/tr><tr><td><strong>Psico-oncolog\u00eda<\/strong><\/td><td>Repercusiones Psico-sociales de la enfermedad oncol\u00f3gica<\/td><\/tr><tr><td><strong>Ensayos cl\u00ednicos<\/strong><\/td><td>Participaci\u00f3n en ensayos cl\u00ednicos de \u00e1mbito nacional e internacional<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Resumen<\/h2>\n\n\n\n<p><\/p>\n\n\n\n<p>El Servicio de Oncolog\u00eda M\u00e9dica del CST desarrolla su actividad adem\u00e1s de a nivel asistencial, tambi\u00e9n como Grupo de Investigaci\u00f3n. Nos basamos en la firme convicci\u00f3n de que la investigaci\u00f3n cl\u00ednica es fundamental no s\u00f3lo para el desarrollo de nuevos tratamientos, sino tambi\u00e9n para analizar aspectos m\u00e1s transversales que tienen un alto impacto en los resultados en salud de los pacientes. Por otra parte, la investigaci\u00f3n cl\u00ednica es imprescindible para el mantenimiento de un esp\u00edritu cient\u00edfico cr\u00edtico en los profesionales, y proporciona tambi\u00e9n excelentes oportunidades terap\u00e9uticas para los enfermos.<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\r\n    <!-- block: cst-accordion-redesign -->\r\n    <section class=\"block-cst-faqs block-cst-accordion  grups-recerca p_te uni-cnt\" style=\"\">\r\n        <div class=\"cst-accordion-wrapper no-image\">\r\n\r\n            \r\n            <div class=\"cst-accordion-content\">\r\n                \r\n                \r\n                                    <ul class=\"demo-accordion accordionjs\" data-active-index=\"false\">\r\n                                                    <!-- Section 1 -->\r\n                            <li>\r\n                                <div>\r\n                                    <h3>Publicaciones<\/h3>\r\n                                <\/div>\r\n                                <div>\r\n                                    <p>Ruda-Santolaria L, Bergerot C, Hernandez J, Pena C, Montana MF, Galindo-Vazquez O, Torres-Blasco N, Castro-Figueroa E, Esenarro L, Sanchez-Ramirez JC, Estap\u00e9 T, Gany F, Costas-Muniz R. Use of telehealth for psychosocial oncology: A mixed methods study about barriers to and opportunities with Latino patients from Latin America, Spain, and the United States. Psychooncology. 2023 Jun 27. doi: 10.1002\/pon.6182. Epub ahead of print. PMID: 37370195.<\/p>\n<p>de Velasco G, Alonso-Gordoa T, Rodr\u00edguez-Vida A, Anguera G, Campayo M, Pinto \u00c1, Ortega EM, Gallardo E, N\u00fa\u00f1ez NF, Garc\u00eda-Carbonero I, Reig O, M\u00e9ndez-Vidal MJ, Fern\u00e1ndez-Calvo O, Cassinello NV, Torregrosa D, L\u00f3pez-Mart\u00edn A, Rosero A, Valiente PG, de Espa\u00f1a CG, Climent MA, Santasusana MD, S\u00e1nchez \u00c1R, Gonz\u00e1lez IC, Afonso R, Garc\u00eda Del Muro X, Casinello J, Fern\u00e1ndez-Parra EM, Garc\u00eda S\u00e1nchez L, Afonso J, Polo SH, Asensio \u00da. Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib. Clin Genitourin Cancer. 2023 Jun;21(3):e166-e174. doi: 10.1016\/j.clgc.2022.11.021. Epub 2022 Dec 5. PMID: 36610891.<\/p>\n<p>Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon IM, Cend\u00f3n-Florez Y, Gutierrez-Pecharroman A, Salles DC, Romero-Laorden N, Lorente D, Gonz\u00e1lez-Peramato P, Calatrava A, Alonso C, Anido U, Ar\u00e9valo-Lobera S, Balma\u00f1a J, Chirivella I, Juan-Fita MJ, Llort G, Y Cajal TR, Almagro E, Alameda D, L\u00f3pez-Casas PP, Herrera B, Mateo J, Pritchard CC, Antonarakis ES, Lotan TL, Rubio-Briones J, Sandhu S, Olmos D. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. Eur J Cancer. 2023 May;185:105-118. doi: 10.1016\/j.ejca.2023.02.022. Epub 2023 Mar 5. PMID: 36972661.<\/p>\n<p>Provencio M, Ortega AL, Coves-Sarto J, Calvo V, Mars\u00e9-Fabregat R, D\u00f3mine M, Guirado M, Carcereny E, Fern\u00e1ndez N, \u00c1lvarez R, Blanco R, Le\u00f3n-Mateos L, S\u00e1nchez-Torres JM, Sullivan IG, Cobo M, S\u00e1nchez-Hern\u00e1ndez A, Massuti B, Sierra-Rodero B, M\u00e1rtinez-Toledo C, Serna-Blasco R, Romero A, Cruz-Berm\u00fadez A. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial. JAMA Oncol. 2023 Mar 1;9(3):344-353. doi: 10.1001\/jamaoncol.2022.5959. PMID: 36520426; PMCID: PMC9856905.<\/p>\n<p>Kim Y, Ting A, Carver CS, Bahcivan O, Bergerot CD, Csaba D, Estape T, Fujisawa D, Goswami SS, Tak Lam WW, Parvu A, Shim EJ, Serpentini S, Takeuchi E, Wang A. International collaboration for assessing unmet needs of cancer survivors and family caregivers: Lens of healthcare professionals. Psychooncology. 2023 Jan;32(1):77-85. doi: 10.1002\/pon.6051. Epub 2022 Oct 19. PMID: 36251612.<br \/>\nEstap\u00e9, T. \u201cLa negaci\u00f3n en el proceso oncol\u00f3gico\u201d, en \u201cEcos iberoamericanos de la psico-oncolog\u00eda\u201d (Compiladora. Ester Daniel), Ed. Paibooks Ediciones, Argentina, 2023. ISBN 978-987-45550-9-0, pp. 59-82.<\/p>\n<p>Donat-Roca, Rafel; T\u00e1rrega, Salom\u00e9; Estap\u00e9-Madinabeitia, T\u00e0nia; Escalona-Marfil, Carles; Ru\u00edz-Moreno, Jorge; Seijas, Roberto; et al. (2023). Spanish Version of the Anterior Cruciate Ligament\u2013Quality of Life Questionnaire: Translation, Cross-cultural Adaptation, and Validation. SAGE Journals. Collection. https:\/\/doi.org\/10.25384\/SAGE.c.6753746.v1.<\/p>\n<p>Bahcivan O, Gutierrez-Maldonado J, Estap\u00e9 T. A single-session Mindfulness-Based Swinging Technique vs. cognitive disputation intervention among women with breast cancer: A pilot randomised controlled study examining the efficacy at 8-week follow-up. Front Psychol. 2022 Oct 20;13:1007065. doi: 10.3389\/fpsyg.2022.1007065. PMID: 36337479; PMCID: PMC9632732.<\/p>\n<p>Carrion IV, Neelamegam M, Estap\u00e9 T, Doering T, Snyder O, Tollinchi E, Estap\u00e9 J. Cancer Prevention and Diagnosis Knowledge among Spanish-speaking Older Latino\/as Residing in Tampa, Florida. Ethn Dis. 2022 Jul 21;32(3):185-192. doi: 10.18865\/ed.32.3.185. PMID: 35909640; PMCID: PMC9311304.<\/p>\n<p>Provencio M, Cobo M, Rodriguez-Abreu D, Calvo V, Carcereny E, Cantero A, Bernab\u00e9 R, Benitez G, Castro RL, Massut\u00ed B, Del Barco E, Garc\u00eda Campelo R, Guirado M, Camps C, Ortega AL, Gonz\u00e1lez Larriba JL, S\u00e1nchez A, Casal J, Sala MA, Juan-Vidal O, Bosch-Barrera J, Oramas J, D\u00f3mine M, Trigo JM, Blanco R, Calzas J, Morilla I, Padilla A, Pimentao J, Sousa PA, Torrente M. Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics. BMC Cancer. 2022 Jul 5;22(1):732. doi: 10.1186\/s12885-022-09830-8. PMID: 35790916; PMCID: PMC9254518.<\/p>\n<p>Bahcivan O, Estap\u00e9 T, Gutierrez-Maldonado J. Efficacy of New Mindfulness-Based Swinging Technique Intervention: A Pilot Randomised Controlled Trial Among Women With Breast Cancer. Front Psychol. 2022 Jul 4;13:863857. doi: 10.3389\/fpsyg.2022.863857. PMID: 35859820; PMCID: PMC9291217.<\/p>\n<p>Riudavets M, Auclin E, Mosteiro M, Dempsey N, Majem M, Lobefaro R, L\u00f3pez-Castro R, Bosch-Barrera J, Pilotto S, Escalera E, Tagliamento M, Mosquera J, Zalcman G, Aboubakar-Nana F, Ponce S, Dal Maso A, Spotti M, Mielgo-Rubio X, Mussat E, Reyes R, Ben\u00edtez JC, Lupinacci L, Duchemann B, De Giglio A, Blaquier J, Audigier-Valette C, Scheffler M, Nadal E, Lopes G, Signorelli D, Garcia-Campelo R, Menis J, Bluthgen V, Campayo M, Recondo G, Besse B, Planchard D, Mezquita L. Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations. Eur J Cancer. 2022 May;167:142-148. doi: 10.1016\/j.ejca.2022.02.014. Epub 2022 Mar 17. PMID: 35307254.<\/p>\n<p>S\u00e1nchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodr\u00edguez-Alonso L, Ramon Y Cajal T, Llort G, Pi\u00f1ol V, L\u00f3pez-Fern\u00e1ndez A, Salces I, Pic\u00f3 MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, L\u00f3pez-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Oca\u00f1a T, Rivero-S\u00e1nchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodr\u00edguez-Moranta F, Balma\u00f1a J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clin Gastroenterol Hepatol. 2022 Mar;20(3):611-621.e9. doi: 10.1016\/j.cgh.2020.11.002. Epub 2020 Nov 3. PMID: 33157315.<\/p>\n<p>Estap\u00e9 T, Phillip EJ, Bergerot CD. Use of telehealth and eHealth technologies in patient care by psycho-oncology service providers in low-middle-income countries during the COVID-19. Psychooncology. 2022 Feb;31(2):334-337. doi: 10.1002\/pon.5797. Epub 2021 Sep 1. PMID: 34467589; PMCID: PMC8646277.<\/p>\n<p>Pinto \u00c1, Reig O, Iglesias C, Gallardo E, Garc\u00eda-Del Muro X, Alonso T, Anguera G, Su\u00e1rez C, Mu\u00f1oz-Langa J, Villalobos-Le\u00f3n L, Rodr\u00edguez-S\u00e1nchez \u00c1, Lainez N, Mart\u00ednez-Ortega E, Campayo M, Velastegui A, Rodriguez-Vida A, Villa-Guzm\u00e1n JC, M\u00e9ndez-Vidal MJ, Rubio G, Garc\u00eda I, Capdevila L, Lambea J, V\u00e1zquez S, Fern\u00e1ndez O, Hernando-Polo S, Cerezo S, Santander C, Garc\u00eda-Marrero R, Zambrana F, Gonz\u00e1lez-Del Alba A, Lazaro-Quintela M, Castellano D, Chirivella I, Anido U, Viana A, Garc\u00eda A, Sotelo M, Ar\u00e9valo MG, Garc\u00eda-Donas J, Hern\u00e1ndez C, Bol\u00f3s MV, Llinares J, Climent MA. Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study. Clin Genitourin Cancer. 2022 Feb;20(1):25-34. doi: 10.1016\/j.clgc.2021.09.006. Epub 2021 Oct 20. PMID: 34789409.<\/p>\n<p>Cheli S, Lam WWT, Estap\u00e9 T, Winterling J, Bahcivan O, Andritsch E, Weis J, Centeno I, Serpentini S, Farkas C, Wengstr\u00f6m Y, Fioretto L, Baider L, Lam CCL, Goldzweig G. Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patients. Psychooncology. 2022 Jan;31(1):46-53. doi: 10.1002\/pon.5775. Epub 2021 Aug 4. Erratum in: Psychooncology. 2022 May;31(5):865-866. PMID: 34314560; PMCID: PMC8420575.<\/p>\n<p>Guti\u00e9rrez L, Royuela A, Carcereny E, L\u00f3pez-Castro R, Rodr\u00edguez-Abreu D, Massuti B, Gonz\u00e1lez-Larriba JL, Garc\u00eda-Campelo R, Bosch-Barrera J, Guirado M, Camps C, D\u00f3mine M, Bernab\u00e9 R, Casal J, Oramas J, Ortega AL, Sala MA, Padilla A, Aguiar D, Juan-Vidal O, Blanco R, Del Barco E, Mart\u00ednez-Banaclocha N, Ben\u00edtez G, de Vega B, Hern\u00e1ndez A, Saigi M, Franco F, Provencio M. Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data. BMC Cancer. 2021 Aug 31;21(1):977.<\/p>\n<p>Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglyt\u0117 M, S\u00e1nchez-Hern\u00e1ndez A, de Juli\u00e1n Campayo M, Garc\u00eda-Gir\u00f3n C, D\u00f3mine M, Blasco A, S\u00e1nchez JM, Oramas J, Bosch-Barrera J, Sala M\u00c1, Sereno M, Ortega AL, Chara L, Hern\u00e1ndez B, Padilla A, Coves J, Blanco R, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila M\u00c1, Romero A. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment. Eur J Cancer. 2021 May;149:61-72. <\/p>\n<p>Poll\u00e1n M, Casla-Barrio S,\u00a0<strong>Alfaro J<\/strong>, Esteban C, Segui-Palmer MA, Lucia A, Mart\u00edn M. Exercise and cancer: a position statement from the Spanish Society of Medical Oncology. Clin Transl Oncol.\u00a0<strong>2020<\/strong>\u00a0Oct;22(10):1710-1729. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s12094-020-02312-y\" target=\"_blank\" rel=\"noreferrer noopener\">10.1007\/s12094-020-02312-y<\/a>. Epub 2020 Feb 13. PMID: 32052383; PMCID: PMC7423809.<\/p>\n<p>Gonzalez-Cao M, Mor\u00e1n T, Dalmau J, Garcia-Corbacho J, Bracht JWP, Bernabe R, Juan O, Castro J de,\u00a0<strong>Blanco R<\/strong>, Drozdowskyj A, Argilaguet J, Meyerhans A, Blanco J, Prado JG, Carrillo J, Clotet B, Massuti B, Provencio M, Molina-Vila MA, Casa CM de las, Garzon M, Cao P, Huang C-Y, Martinez-Picado J, Rosell R. Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study. JAMA Oncol.\u00a0<strong>2020<\/strong>;6(7):1063-1067.<\/p>\n<p>Gonz\u00e1lez-Santiago S, Ram\u00f3n Y Cajal T, Aguirre E, Al\u00e9s-Mart\u00ednez JE, Andr\u00e9s R, Balma\u00f1a J, Gra\u00f1a B, Herrero A,\u00a0<strong>Llort G<\/strong>, Gonz\u00e1lez-Del-Alba A; SEOM Hereditary Cancer Working Group. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019). Clin Transl Oncol.\u00a0<strong>2020<\/strong>\u00a0Feb;22(2):193-200. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s12094-019-02262-0\" target=\"_blank\" rel=\"noreferrer noopener\">10.1007\/s12094-019-02262-0<\/a>. Epub 2019 Dec 30. PMID: 31889241.<\/p>\n<p><strong>Remei Blanco<\/strong>. Cap\u00edtol\u00a0 Tratamiento inmunomodulador en el anciano con c\u00e1ncer. Mar\u00eda Jos\u00e9 Molina Garrido y Lodovicco Balducci . Fundamentos en oncogeriatr\u00eda. Tratado de oncolog\u00eda m\u00e9dica en el paciente anciano. M\u00e9deric Ediciones, 24\/10\/<strong>2019<\/strong>.<\/p>\n<p>Capdevila J, Teul\u00e9 A, Barriuso J, Castellano D, Lopez C, Manzano JL, Alonso V, Garc\u00eda-Carbonero R,\u00a0<strong>Dotor E<\/strong>, Matos I, Custodio A, Casanovas O, Salazar R; EVERLAR study investigators. Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study. Oncologist.\u00a0<strong>2019<\/strong>\u00a0Jan;24(1):38-46. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1634\/theoncologist.2017-0622\" target=\"_blank\" rel=\"noreferrer noopener\">10.1634\/theoncologist.2017-0622<\/a>. Epub 2018 May 23. PMID: 29794066; PMCID: PMC6324631.<\/p>\n<p>Pic\u00f3 MD, Castillejo A, Murcia \u00d3, Giner-Calabuig M, Alustiza M, S\u00e1nchez A, Moreira L, Pellise M, Castells A, Carrillo-Palau M, Ramon Y Cajal T, Gisbert-Beamud A,\u00a0<strong>Llort G<\/strong>, Yag\u00fce C, L\u00f3pez-Fern\u00e1ndez A, Alvarez-Urturi C, Cubiella J, Rivas L, Rodr\u00edguez-Alcalde D, Herraiz M, Garau C, Dolz C, Bujanda L, Cid L, Pov\u00e9s C, Garzon M, Salces I, Ponce M, Hern\u00e1ndez-Villalba L, Alenda C, Balaguer F, Soto JL, Jover R. Clinical and Pathological Characterization of Lynch-Like Syndrome. Clin Gastroenterol Hepatol. 2020 Feb;18(2):368-374.e1. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1016\/j.cgh.2019.06.012\" target=\"_blank\" rel=\"noreferrer noopener\">10.1016\/j.cgh.2019.06.012<\/a>. Epub 2019 Jun 17. PMID: 31220642.<\/p>\n<p>Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels. Feliubadal\u00f3 L, L\u00f3pez-Fern\u00e1ndez A, Pineda M, D\u00edez O, Del Valle J, Guti\u00e9rrez-Enr\u00edquez S, Teul\u00e9 A, Gonz\u00e1lez S, Stjepanovic N, Salinas M, Capell\u00e1 G, Brunet J, L\u00e1zaro C, Balma\u00f1a J;\u00a0<strong>Catalan Hereditary Cancer Group (Gemma Llort)<\/strong>. Int J Cancer.\u00a0<strong>2019<\/strong>\u00a0Nov 15;145(10):2682-2691.<\/p>\n<p>Sullivan I, Riera P,\u00a0<strong>Andr\u00e9s M<\/strong>, Alt\u00e9s A, Majem M,\u00a0<strong>Blanco R<\/strong>, Capdevila L, Barba A, Barnadas A, Salazar J. Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients. Angiogenesis.\u00a0<strong>2019<\/strong>\u00a0Aug;22(3):433-440. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s10456-019-09668-y\" target=\"_blank\" rel=\"noreferrer noopener\">10.1007\/s10456-019-09668-y<\/a>. Epub 2019 Apr 11. PMID: 30977010.<\/p>\n<p>Clav\u00e9 S, Rodon N, Pijuan L, D\u00edaz O, Lorenzo M, Rocha P, Taus \u00c1,\u00a0<strong>Blanco R<\/strong>, Bosch-Barrera J, Reguart N, de la Torre N, Oliveras G, Espinet B, Bellosillo B, Puig X, Arriola E, Salido M. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns. Clin Lung Cancer. Published online February 26,\u00a0<strong>2019<\/strong>. doi:<a href=\"https:\/\/doi.org\/10.1016\/j.cllc.2019.02.008\" target=\"_blank\" rel=\"noreferrer noopener\">10.1016\/j.cllc.2019.02.008<\/a><\/p>\n<p>D Rodriguez Abreu, M Guirado, C.J. Camps Herrero, J. Bosch Barrera, R. Bernab\u00e9, J. Casal, M.-R. Garc\u00eda-Campelo, J.L. Gonzalez-Larriba, B. Massuti Sureda, A.L. Ortega Granados, M. Domine Gomez, M.A. Sala, A. Padilla, E. Del Barco Morillo, J.M. Oramas Rodriguez,\u00a0<strong>R. Blanco Guerrero<\/strong>, D. Aguiar Bujanda, R. L\u00f3pez Castro, E. Carcereny Costa, M. Provencio. Biomarker testing of lung cancer in Spain. Annals of Oncology.\u00a0<strong>2019<\/strong>;30:v749.<\/p>\n<p>Mor\u00e1n T, Felip E, Bosch-Barrera J, de Aguirre I, Ramirez JL, Mesia C, Carcereny E, Roa D, Sais E, Garc\u00eda Y,\u00a0<strong>Blanco R,<\/strong>\u00a0Sanchez S, Villacorta CR, Queralt C, Velarde JM, Rosell R. Monitoring EGFR-T790M mutation in serum\/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer. Oncotarget. 2018 Jun 5;9(43):27074-27086. doi:\u00a0<a href=\"https:\/\/doi.org\/10.18632\/oncotarget.25478\" target=\"_blank\" rel=\"noreferrer noopener\">10.18632\/oncotarget.25478.<\/a>\u00a0Erratum in: Oncotarget.\u00a0<strong>2019<\/strong>\u00a0Apr 2;10(26):2576. PMID: 29930751; PMCID: PMC6007479.<\/p>\n<p>Molina-Garrido MJ, Guill\u00e9n-Ponce C,\u00a0<strong>Blanco R<\/strong>, Salda\u00f1a J, Feli\u00fa J, Antonio M, L\u00f3pez-Mongil R, Ramos Cordero P, Giron\u00e9s R; Working Group on Oncogeriatrics of the Spanish Society of Medical Oncology (SEOM). Delphi consensus of an expert committee in oncogeriatrics regarding comprehensive geriatric assessment in seniors with cancer in Spain. J Geriatr Oncol.\u00a0<strong>2018<\/strong>\u00a0Jul;9(4):337-345. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1016\/j.jgo.2017.11.012\" target=\"_blank\" rel=\"noreferrer noopener\">10.1016\/j.jgo.2017.11.012<\/a>. Epub 2017 Dec 13. PMID: 29248435.<\/p>\n<p>Giron\u00e9s Sarri\u00f3 R, Antonio Rebollo M, Molina Garrido MJ, Guill\u00e9n-Ponce C,\u00a0<strong>Blanco R<\/strong>, Gonzalez Flores E, Salda\u00f1a J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM). General recommendations paper on the management of older patients with cancer: the SEOM geriatric oncology task force\u2019s position statement. Clin Transl Oncol.\u00a0<strong>2018<\/strong>\u00a0Oct;20(10):1246-1251. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1016\/10.1007\/s12094-018-1856-x\" target=\"_blank\" rel=\"noreferrer noopener\">10.1007\/s12094-018-1856-x<\/a>. Epub 2018 Apr 9. PMID: 29633183; PMCID: PMC6153856.<\/p>\n<p>Giron\u00e9s R, Morilla I, Guillen-Ponce C, Torregrosa MD, Paredero I, Bustamante E, Del Barco S, Soler G, Losada B, Visa L, Llabr\u00e9s E, Fox B, Firvida JL,\u00a0<strong>Blanco R<\/strong>, Antonio M, Aparisi F, Pi-Figueras M, Gonzalez-Flores E, Molina-Garrido MJ, Salda\u00f1a J; Spanish Working Group on Geriatric Oncology of the Spanish Society of Medical Oncology (SEOM). Geriatric oncology in Spain: survey results and analysis of the current situation. Clin Transl Oncol.\u00a0<strong>2018<\/strong>\u00a0Aug;20(8):1087-1092. doi:\u00a0<a href=\"https:\/\/doi.org\/10.1007\/s12094-017-1813-0\" target=\"_blank\" rel=\"noreferrer noopener\">10.1007\/s12094-017-1813-0<\/a>. Epub 2017 Dec 11. PMID: 29327240; PMCID: PMC6061214.<\/p>\n<p><strong>Blanco, R;<\/strong>\u00a0Capo, M; Libr\u00e1n, A,\u00a0<strong>Alfaro J, Dotor E,\u00a0<\/strong>Fern\u00e1ndez-Morales LA<strong>,\u00a0<\/strong>Guerra D,<strong>\u00a0Jovell E,\u00a0<\/strong>Llonch M<strong>, Pisa A, Arcusa A.<\/strong>\u00a0Multidisciplinary treatment planning in elderly patients with cancer: a prospective observational study. Journal Of Community And Supportive Oncology\u00a0<strong>2016<\/strong>. 14 \u2013 11, pp. 466 \u2013 472.<\/p>\n<p>Provencio M, Serna-Blasco R, Franco F, Calvo V, Royuela A, Auglyt\u0117 M, S\u00e1nchez-Hern\u00e1ndez A, de Juli\u00e1n Campayo M, Garc\u00eda-Gir\u00f3n C, D\u00f3mine M, Blasco A, S\u00e1nchez JM, Oramas J, Bosch-Barrera J, Sala M\u00c1, Sereno M, Ortega AL, Chara L, Hern\u00e1ndez B, Padilla A, Coves J, <strong>Blanco R<\/strong>, Balsalobre J, Mielgo X, Bueno C, Jantus-Lewintre E, Molina-Vila M\u00c1, Romero A. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment. Eur J Cancer. <strong>2021<\/strong> May;149:61-72.<\/p>\n<p>Guti\u00e9rrez L, Royuela A, Carcereny E, L\u00f3pez-Castro R, Rodr\u00edguez-Abreu D, Massuti B, Gonz\u00e1lez-Larriba JL, Garc\u00eda-Campelo R, Bosch-Barrera J, Guirado M, Camps C, D\u00f3mine M, Bernab\u00e9 R, Casal J, Oramas J, Ortega AL, Sala MA, Padilla A, Aguiar D, Juan-Vidal O, <strong>Blanco R<\/strong>, Del Barco E, Mart\u00ednez-Banaclocha N, Ben\u00edtez G, de Vega B, Hern\u00e1ndez A, Saigi M, Franco F, Provencio M. Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data. BMC Cancer. <strong>2021<\/strong> Aug 31;21(1):977.<\/p>\n                                <\/div>\r\n                            <\/li>\r\n                                            <\/ul>\r\n                            <\/div>\r\n        <\/div>\r\n    <\/section>\r\n    <!-- end block: cst-accordion-redesign -->\r\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><\/p>\n","protected":false},"template":"","class_list":["post-25388","grup_recerca","type-grup_recerca","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Oncolog\u00eda - CST<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oncolog\u00eda - CST\" \/>\n<meta property=\"og:description\" content=\"GRUPOS DE INVESTIGACI\u00d3N Oncolog\u00eda Miembros Remei Blanco Guerrero (PhD, MD)Jordi Alfaro Gamero (MD)Emma Dotor Navarro (MD)Aleydis Pisa Gatell (MD)Ana Raquel Jim\u00e9nez Macedo (MD)Gemma Llort Pursals (MD)Marta Andr\u00e9s Grany\u00f3 (MD)Maria Mar\u00edn Alcal\u00e1 (MD)Rosa Maria P\u00e9rez Ramos (MD)M\u00f3nica Juncosa Domingo (MD)Marc Campayo Guillaumes (PhD, MD)Carme Aracil Noelle (PhD)Lester Martinez Navarro Tania Estap\u00e9 Madinabeitia PhD (PC, NPS)Gloria Arenas [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/\" \/>\n<meta property=\"og:site_name\" content=\"CST\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-17T07:11:18+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/\",\"url\":\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/\",\"name\":\"Oncolog\u00eda - CST\",\"isPartOf\":{\"@id\":\"https:\/\/cst.cat\/es\/#website\"},\"datePublished\":\"2024-06-07T11:11:40+00:00\",\"dateModified\":\"2024-06-17T07:11:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/cst.cat\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oncolog\u00eda\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cst.cat\/es\/#website\",\"url\":\"https:\/\/cst.cat\/es\/\",\"name\":\"CST\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cst.cat\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cst.cat\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cst.cat\/es\/#organization\",\"name\":\"Consorci Sanitari de Terrassa\",\"url\":\"https:\/\/cst.cat\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/cst.cat\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cst.cat\/wp-content\/uploads\/2021\/09\/logo-header.svg\",\"contentUrl\":\"https:\/\/cst.cat\/wp-content\/uploads\/2021\/09\/logo-header.svg\",\"width\":90,\"height\":32,\"caption\":\"Consorci Sanitari de Terrassa\"},\"image\":{\"@id\":\"https:\/\/cst.cat\/es\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oncolog\u00eda - CST","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/","og_locale":"es_ES","og_type":"article","og_title":"Oncolog\u00eda - CST","og_description":"GRUPOS DE INVESTIGACI\u00d3N Oncolog\u00eda Miembros Remei Blanco Guerrero (PhD, MD)Jordi Alfaro Gamero (MD)Emma Dotor Navarro (MD)Aleydis Pisa Gatell (MD)Ana Raquel Jim\u00e9nez Macedo (MD)Gemma Llort Pursals (MD)Marta Andr\u00e9s Grany\u00f3 (MD)Maria Mar\u00edn Alcal\u00e1 (MD)Rosa Maria P\u00e9rez Ramos (MD)M\u00f3nica Juncosa Domingo (MD)Marc Campayo Guillaumes (PhD, MD)Carme Aracil Noelle (PhD)Lester Martinez Navarro Tania Estap\u00e9 Madinabeitia PhD (PC, NPS)Gloria Arenas [&hellip;]","og_url":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/","og_site_name":"CST","article_modified_time":"2024-06-17T07:11:18+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/","url":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/","name":"Oncolog\u00eda - CST","isPartOf":{"@id":"https:\/\/cst.cat\/es\/#website"},"datePublished":"2024-06-07T11:11:40+00:00","dateModified":"2024-06-17T07:11:18+00:00","breadcrumb":{"@id":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cst.cat\/es\/grup-recerca\/oncologia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/cst.cat\/es\/"},{"@type":"ListItem","position":2,"name":"Oncolog\u00eda"}]},{"@type":"WebSite","@id":"https:\/\/cst.cat\/es\/#website","url":"https:\/\/cst.cat\/es\/","name":"CST","description":"","publisher":{"@id":"https:\/\/cst.cat\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cst.cat\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/cst.cat\/es\/#organization","name":"Consorci Sanitari de Terrassa","url":"https:\/\/cst.cat\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/cst.cat\/es\/#\/schema\/logo\/image\/","url":"https:\/\/cst.cat\/wp-content\/uploads\/2021\/09\/logo-header.svg","contentUrl":"https:\/\/cst.cat\/wp-content\/uploads\/2021\/09\/logo-header.svg","width":90,"height":32,"caption":"Consorci Sanitari de Terrassa"},"image":{"@id":"https:\/\/cst.cat\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cst.cat\/es\/wp-json\/wp\/v2\/grup_recerca\/25388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cst.cat\/es\/wp-json\/wp\/v2\/grup_recerca"}],"about":[{"href":"https:\/\/cst.cat\/es\/wp-json\/wp\/v2\/types\/grup_recerca"}],"wp:attachment":[{"href":"https:\/\/cst.cat\/es\/wp-json\/wp\/v2\/media?parent=25388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}